Publications

Publications

Pre-existing conditions associated with post-acute sequelae of COVID-19

  • Post-acute sequelae of COVID-19 (PASC) has been increasingly observed to occur in patients who have been infected with SARS-CoV-2
  • To date, it is not known which comorbidities may increase an individual’s risk of developing PASC.
  • In our longitudinal cohort study, we found that those with autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, or multiple sclerosis were significantly more likely to develop PASC following SARS-CoV-2 infection than individuals without these comorbidities.

Read Full Text

Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT

The latest research from the Arizona CoVHORT followed persons with a confirmed SARS-CoV-2 infection from May 2020 through October 2021 in order to determine how acute gastrointestinal symptoms (GI) persist following COVID-19. It’s important to understand if there’s an association between SARS-CoV-2 infection and persistent GI symptoms because these symptoms can have considerable impacts to a person’s quality of life and result in a diagnosis of long-term GI disorders like Irritable Bowel Syndrome (IBS). We found that persons with GI symptoms during their acute COVID-19 infection had a 4 times higher odds of persistent GI symptoms 45 days or more after infection. These GI symptoms lasted 8 months on average following initial acute infection and 30% had symptoms consistent with an IBS diagnosis. We also discovered that this relationship was modified by pre-existing conditions – if a person had no pre-existing conditions they had an 8 times higher odds of persistent GI symptoms, those with at least one had a 3 times higher odds. You can read more about our results in this article!

Read Full Text

Elucidating symptoms of COVID-19 illness in the Arizona CoVHORT: a longitudinal cohort study

The most commonly reported symptoms of acute COVID-19 in the Arizona CoVHORT were fatigue (82.2%), headache (74.6%), aches, pains or sore muscles (66.3%), loss of taste or smell (62.8) and cough (61.9%). COVID-19-positive participants were more likely than negative participants to experience loss of taste and smell, bone or nerve pain, headache, nausea, or diarrhea. When comparing confirmed COVID-19 cases with either confirmed negative or untested participants, the pattern of symptoms for those with SARS-CoV-2 infection are different from symptoms from other potential circulating pathogens.

Read Full Text

SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT Study

We observed 16% of the participants in our sample reported changes to their menstrual cycle after having a COVID-19 infection. The most commonly reported changes were: irregular menstruation (60%), increase in premenstrual syndrome symptoms (PMS) (45%), and infrequent menstruation (35%). Those participants who reported changes to their menstrual cycle were more likely to report a greater number of Covid-19 symptoms, including fatigue, headache, body aches and pains, and shortness of breath and to identify as Hispanic when compared to those who reported no changes to their menstrual cycle.

Read Full Text

Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT

In this manuscript, we sought to examine the clinical presentation and duration of illness of post-acute sequelae of COVID-19 (PASC), or long-COVID, among participants of the CoVHORT who where not hospitalized for their acute SARS-CoV-2 infection. As of February 24, 2021, there were 303 participants in the CoVHORT who had reported a positive test result and having had COVID-19. Among these 303 individuals, 208 (68.7%) participants reported still experiencing at least one symptom 30 days after their COVID-19 diagnosis and were classified as having PASC, or long-COVID.

Read Full Text

Design of the Arizona CoVHORT: A Population-Based COVID-19 Cohort

This manuscript describes a scalable study design that utilizes a wide range of recruitment sources, leveraging electronic data collection to capture and link longitudinal participant data on the current and emerging issues associated with the COVID-19 pandemic.

Read Full Text

Become part of the solution!

Fight the virus, join the CoVHORT